NCT00162149 - ATV/Ritonavir Nevirapine Interaction (USPAC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

HIV Infections

Interventions

DRUG

Nevirapine

Tablets, Oral, 200 mg, Twice daily, 3 days.

DRUG

Nevirapine + Atazanavir/Ritonavir

Tablets + Capsules/Capsules, Oral, 200 mg + 300/100 mg, twice daily + once daily, 10 days.

DRUG

Nevirapine + Atazanavir/Ritonavir

Tablets + Capsules/Capsules, Oral, 200 mg + 400/100 mg, twice daily + once daily, 10 days.

DRUG

Atazanavir + Ritonavir

Capsules/capsules, Oral, 300/100 mg, once daily, 10 days.

Trial Locations (3)

Local Institution, Pomona

Local Institution, Seattle

Local Institution, London